The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia

Leuk Res. 2020 Jan:88:106285. doi: 10.1016/j.leukres.2019.106285. Epub 2019 Dec 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Availability
  • Dose-Response Relationship, Drug
  • Female
  • Gene Expression Regulation, Leukemic / drug effects
  • Genes, abl / genetics
  • Humans
  • Imatinib Mesylate / analysis
  • Imatinib Mesylate / blood
  • Imatinib Mesylate / pharmacokinetics*
  • Imatinib Mesylate / therapeutic use
  • Intracellular Space / chemistry
  • Intracellular Space / metabolism*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Male
  • Octamer Transcription Factor-1 / genetics
  • Octamer Transcription Factor-1 / metabolism
  • Predictive Value of Tests
  • Prognosis
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Octamer Transcription Factor-1
  • Imatinib Mesylate